ENTRESTO (Novartis Pharmaceuticals Corporation)


Welcome to the PulseAid listing for the ENTRESTO drug offered from Novartis Pharmaceuticals Corporation. This Neprilysin Inhibitor [EPC],Neprilysin Inhibitors [MoA],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novartis Pharmaceuticals Corporation
NON-PROPRIETARY NAME: Sacubitril and Valsartan
SUBSTANCE NAME: SACUBITRIL; VALSARTAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Neprilysin Inhibitor [EPC],Neprilysin Inhibitors [MoA],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-07-07
END MARKETING DATE: 0000-00-00


ENTRESTO HUMAN PRESCRIPTION DRUG Details:

Item DescriptionENTRESTO from Novartis Pharmaceuticals Corporation
LABELER NAME: Novartis Pharmaceuticals Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 24; 26(mg/1; mg/1)
START MARKETING DATE: 2015-07-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0078-0659_cc41a112-81a3-42e9-87fa-bc7592cf2492
PRODUCT NDC: 0078-0659
APPLICATION NUMBER: NDA207620

Other SACUBITRIL; VALSARTAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Novartis Pharmaceuticals CorporationENTRESTO